Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1501-1510 of 1,779) with videos related to

Pageof 178
Sort By:
Mabs|April 20, 2010
Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity?Randall J Brezski, Robert E Jordan
Mabs|August 21, 2010
A novel class of anti-IL-12p40 antibodies: potent neutralization via inhibition of IL-12-IL-12Rβ2 and IL-23-IL-23RAdam W Clarke, Lynn Poulton, Hoi Yi Wai, et al.
Mabs|August 21, 2010
Fluorescent Citrine-IgG fusion proteins produced in mammalian cellsAlexander K Haas, Christoffer von Schwerin, Daniela Matscheko, et al.
Mabs|April 21, 2010
Identification of methionine sulfoxide diastereomers in immunoglobulin gamma antibodies using methionine sulfoxide reductase enzymesHui K Khor, Michael E Jacoby, Thomas C Squier, et al.
Mabs|August 9, 2011
Bridging the gap: facilities and technologies for development of early stage therapeutic mAb candidatesTrent P Munro, Stephen M Mahler, Edwin P Huang, et al.
Mabs|November 30, 2011
Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptorKlaus Koefoed, Lucilla Steinaa, Josefine Nielsen Søderberg, et al.
Mabs|February 14, 2012
World Bispecific Antibody Summit, September 27-28, 2011, Boston, MAEugen Dhimolea, Janice M Reichert
Mabs|February 14, 2012
Immunotoxins constructed with chimeric, short-lived anti-CD22 monoclonal antibodies induce less vascular leak without loss of cytotoxicityXiao-yun Liu, Laurentiu M Pop, John Schindler, et al.
Mabs|February 14, 2012
Tolerability, pharmacokinetics and pharmacodynamics of CMAB007, a humanized anti-immunoglobulin E monoclonal antibody, in healthy Chinese subjectsBo Zhou, Birong Lin, Jing Li, et al.
Mabs|November 25, 2010
Targeting antibodies to the cytoplasmAndrea L J Marschall, André Frenzel, Thomas Schirrmann, et al.
Pageof 178

Showing results (1501-1510 of 1,779) with videos related to

Sort By:
Pageof 178
Mabs|April 20, 2010
Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity?Randall J Brezski, Robert E Jordan
Mabs|August 21, 2010
A novel class of anti-IL-12p40 antibodies: potent neutralization via inhibition of IL-12-IL-12Rβ2 and IL-23-IL-23RAdam W Clarke, Lynn Poulton, Hoi Yi Wai, et al.
Mabs|August 21, 2010
Fluorescent Citrine-IgG fusion proteins produced in mammalian cellsAlexander K Haas, Christoffer von Schwerin, Daniela Matscheko, et al.
Mabs|April 21, 2010
Identification of methionine sulfoxide diastereomers in immunoglobulin gamma antibodies using methionine sulfoxide reductase enzymesHui K Khor, Michael E Jacoby, Thomas C Squier, et al.
Mabs|August 9, 2011
Bridging the gap: facilities and technologies for development of early stage therapeutic mAb candidatesTrent P Munro, Stephen M Mahler, Edwin P Huang, et al.
Mabs|November 30, 2011
Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptorKlaus Koefoed, Lucilla Steinaa, Josefine Nielsen Søderberg, et al.
Mabs|February 14, 2012
World Bispecific Antibody Summit, September 27-28, 2011, Boston, MAEugen Dhimolea, Janice M Reichert
Mabs|February 14, 2012
Immunotoxins constructed with chimeric, short-lived anti-CD22 monoclonal antibodies induce less vascular leak without loss of cytotoxicityXiao-yun Liu, Laurentiu M Pop, John Schindler, et al.
Mabs|February 14, 2012
Tolerability, pharmacokinetics and pharmacodynamics of CMAB007, a humanized anti-immunoglobulin E monoclonal antibody, in healthy Chinese subjectsBo Zhou, Birong Lin, Jing Li, et al.
Mabs|November 25, 2010
Targeting antibodies to the cytoplasmAndrea L J Marschall, André Frenzel, Thomas Schirrmann, et al.
Pageof 178